Anterogen Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW147 |
Market Cap |
KRW753.21 B |
Shares Outstanding |
7.95 M |
Public Float |
4.78 M |
Address |
Unit 405, Namsung Plaza Seoul SL 08589 Korea, Republic Of |
Employees | - |
Website | http://www.anterogen.com |
Updated | 09/14/2018 |
Anterogen Co., Ltd. develops stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell and stem cell conditioned media. In addition, It also offers stem cell banking and analysis services. |